Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/14338
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDuncan, M-
dc.contributor.authorDeane, J-
dc.contributor.authorWhite, PD-
dc.contributor.authorRidge, D-
dc.contributor.authorRoylance, R-
dc.contributor.authorKorszun, A-
dc.contributor.authorChalder, T-
dc.contributor.authorBhui, KS-
dc.contributor.authorThaha, MA-
dc.contributor.authorBourke, L-
dc.contributor.authorTaylor, S-
dc.contributor.authorSandra, E-
dc.contributor.authorMcCrone, P-
dc.contributor.authorMorgan, A-
dc.contributor.authorJones, L-
dc.contributor.authorEva, G-
dc.contributor.authorGribben, J-
dc.date.accessioned2017-03-30T10:14:37Z-
dc.date.available2017-03-11-
dc.date.available2017-03-30T10:14:37Z-
dc.date.issued2017-
dc.identifier.citationBMC Cancer, 17 (1): (2017)en_US
dc.identifier.issn1471-2407-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/14338-
dc.description.abstractBackground: Approximately one third of cancer survivors in the United Kingdom face ongoing and debilitating psychological and physical symptoms related to poor quality of life. Very little is known about current post-cancer treatment services. Methods: Oncology healthcare professionals (HCPs) were invited to take part in a survey, which gathered both quantitative and free text data about the content and delivery of cancer aftercare and patient needs. Analysis involved descriptive statistics and content analysis. Results: There were 163 complete responses from 278 survey participants; 70% of NHS acute trusts provided data. HCPs views on patient post-cancer treatment needs were most frequently: fear of recurrence (95%), fatigue (94%), changes in physical capabilities (89%), anxiety (89%) and depression (88%). A median number of 2 aftercare sessions were provided (interquartile range: 1,4) lasting between 30 and 60 min. Usually these were provided face-to-face and intermittently by a HCP. However, sessions did not necessarily address the issues HCPs asserted as important. Themes from free-text responses highlighted inconsistencies in care, uncertain funding for services and omission of some evidence based approaches. Conclusion: Provision of post-cancer treatment follow-up care is neither universal nor consistent in the NHS, nor does it address needs HCPs identified as most important.en_US
dc.description.sponsorshipThis article presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Reference Number RP-DG-1212-10014).en_US
dc.language.isoenen_US
dc.publisherBioMed Centralen_US
dc.subjectCanceren_US
dc.subjectSurveyen_US
dc.subjectQuality of Lifeen_US
dc.subjectNHSen_US
dc.subjectPost-treatmenten_US
dc.subjectFollow-upen_US
dc.titleA survey to determine usual care after cancer treatment within the United Kingdom national health serviceen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1186/s12885-017-3172-1-
dc.relation.isPartOfBMC Cancer-
pubs.issue1-
pubs.publication-statusPublished-
pubs.volume17-
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf394.78 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.